SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

While Pneumocystis pneumonia (PcP) still impacts the AIDS patients, it has a growing importance in immunosuppressed HIV-negative patients. To determine the anti-Pneumocystis therapeutic efficacy of new compounds, animal and in vitro models have been developed. Indeed, well-designed mouse or rat expe...

Full description

Bibliographic Details
Main Authors: Annie Standaert-Vitse, Cécile-Marie Aliouat-Denis, Anna Martinez, Sara Khalife, Muriel Pottier, Nausicaa Gantois, Eduardo Dei-Cas, El Moukhtar Aliouat
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0130358

Internet

https://doi.org/10.1371/journal.pone.0130358

Similar Items